---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-210639"
form_type: "8-K"
ticker: "AMRX"
cik: "0001723128"
company_name: "Amneal Pharmaceuticals, Inc."
filed_at: "2022-08-03T23:59:59+00:00"
generated_at: "2026-06-24T05:19:07.274653+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Amneal appoints Deborah M. Autor to Board of Directors, effective July 29, 2022

## Summary
- Deborah M. Autor appointed independent director; will serve on Conflicts Committee.
- Autor previously FDA Deputy Commissioner and Global Head at AstraZeneca and Mylan.
- Board now comprises 11 directors following her appointment.

## SEC filing metadata
- accession: 0001193125-22-210639
- form_type: 8-K
- ticker: AMRX
- cik: 0001723128
- company_name: Amneal Pharmaceuticals, Inc.
- filed_at: 2022-08-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1723128/000119312522210639/0001193125-22-210639-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1723128/000119312522210639/d384456d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-210639
- JSON: https://secwatch.observer/filing/0001193125-22-210639.json
- Plain text: https://secwatch.observer/filing/0001193125-22-210639.txt

## Key facts
- Executive change
  Deborah M. Autor was appointed as Director at Amneal Pharmaceuticals, Inc..
  - Action: appointed
  - Role: Director
  source text: On July 29, 2022, the Board of Directors (the “ Board ”) of Amneal Pharmaceuticals, Inc. (the “ Company ”) appointed Deborah M. Autor to the Company’s Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1723128/000119312522210639/0001193125-22-210639-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.